Hints and tips:
...Dealmaking in the sector has sped up over the past few years, including Abbott’s $25bn takeover of St Jude and Medtronic’s $42.9bn acquisition of Covidien, as companies seek to build scale as industry margins...
...“It’s a Cinderella story,” said Stacey Schultz-Cherry, an infectious disease specialist at St Jude’s Children’s Research Hospital in Tennessee....
...WINNER: Mark Barnes Partner, Ropes & Gray After five years as executive vice-president at St Jude Children’s Research Hospital in Memphis and then as an adviser and senior associate provost for research...
...In April last year, Abbott announced a $25bn acquisition of St Jude Medical. Clinching both deals would see its debt soar from $9bn to $31bn, the FT has previously reported....
...(The Lancet, St Judes) China and Africa Chinese interventions in African health are growing but operate very differently from traditional aid programmes....
...For example: Doctors Without Borders; Charity Water; St Jude's Children's Research Hospital; and the ASPCA. But, um, there are also plenty of questionable entities registered as nonprofits in the US....
...There are plenty of others, including St Jude Medical (acquired by Abbott Laboratories in January of this year), which is currently battling lawsuits relating to vulnerabilities in its implantable cardiac...
...Chris Frenz, director of infrastructure at the Interfaith Medical Center, a New York hospital, said that medical device manufacturers should all include the ability to update their devices, and be clear...
...The most common form of childhood cancer costs on average $292,000 to treat, says St Jude Children’s Research Hospital in Memphis, Tennessee....
...St Jude Medical has filed a suit against Muddy Waters, a hedge fund that said last month that the company’s cardiac pacemakers were vulnerable to cyber attacks, alleging that it intentionally made misleading...
...Muddy Waters accused Minnesota company St Jude Medical of being vulnerable to a cyber attack that could crash its cardiac pacemakers....
...St Jude Medical has filed a lawsuit against a hedge fund that last month claimed its cardiac pacemakers were vulnerable to cyber attacks, alleging it concocted an “insidious scheme” to knock down the group...
...Now it is using a cyber security firm and a cardio electrophysiologist to allege that St Jude Medical makes pacemakers that can be hacked and should be recalled....
...He said he would not implant the St Jude Medical pacemakers in patients until the problem was fixed....
...But in April it announced a $25bn acquisition of St Jude Medical. Clinching both deals would see its debt soar from $9bn to $31bn....
...St Jude Medical, a pacemaker manufacturer, was accused in August of having a security flaw in its devices in a report propagated by Muddy Waters....
...Abbott’s acquisition of St Jude could spark a fresh wave of healthcare M&A, with a particular focus in the medical devices and technology focused medical equipment....
...Under the terms, Illinois-based Abbott will pay $46.75 in cash plus 0.8708 Abbott shares for each St Jude share, valuing the medical devices company at about $85 per share....
...The union of medical device makers Abbott Laboratories and St Jude Medical was rumoured last year. Sanofi felt good enough to make a $9bn hostile bid for biotech upstart Medivation....
...US pharmaceutical Abbott Laboratories also on Thursday announced a $25bn deal for St Jude Medical, while France’s Sanofi earlier today went public with the details of an unsolicited bid for San Francisco-based...
...So we’ll also keep an eye on St Jude Medical’s defamation lawsuit in Minnesota against Muddy Waters and MedSec Holdings, after their report claiming its pacemaker devices were unsafe earlier this year....
...The largest was Abbott’s $30bn agreed takeover of St Jude Medical in a cash-and-stock deal that would bring together two of the leading US manufacturers of heart-related medical devices....
...Abbott Healthcare, which AbbVie was spun out of in 2013, said it would buy St Jude, a medical device group, for $25bn, while France’s Sanofi launched an unsolicited $9.3bn bid for San Francisco-based Medivation...
...Abbott and St Jude, which is based in St Paul, Minnesota, already have a strong alliance in the field of cardiovascular devices and sell their portfolio of products jointly to hospitals....
...Elsewhere, St Jude Medical, a maker of devices for the heart-care industry, surged by 25.5 per cent to $77.78 after Abbott Laboratories said it agreed to buy the group for $25bn....
International Edition